The most common side effects of all five FDA-approved drugs include: Nausea Vomiting Diarrhea or constipation Stomach pain Other side effects that may occur include: Indigestion Gas/burping Bloating Tiredness Low blood sugar Decreased appetite Hair loss Injection site reactions (not applicable to Rybelsus, which is taken by mouth) Symptoms of a serious allergic reaction, such as hives, trouble breathing, or swelling of the face, lips, tongue, or throat, require emergency medical help
The Global Market Landscape for GLP-1 Medications GLP-1 therapies are rapidly expanding in Europe, the Asia-Pacific region, including India and China, driven by rising obesity and supportive healthcare initiatives
Skin lightening, contrary to advertised claims, is not permanent
The semaglutide and tirzepatide trials changed that expectation: Semaglutide 2.4 mg once weekly produced average weight loss around 15% at ~68 weeks in adults without diabetes, with a substantial fraction of participants losing 1520% of baseline weight
However, ongoing litigation and different legal mechanisms may still allow some compounding operations
0% [25, 50], p = 0.04)